Moving promising research findings to the clinic: Methodological issues in the design and conduct of clinical trials of retinoids

International Journal of Cancer

Volumn 70, Issue 4, 1997, Pages 467-469

  Arnold, Andrew ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b JURAVINSKI CANCER CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MOFAROTENE; RETINOID;

ARTICLE; CANCER; CLINICAL TRIAL; HUMAN; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CASE-CONTROL STUDIES; CLINICAL TRIALS; HUMANS; RESEARCH DESIGN; RETINOIDS;

EID: 0031020441     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970207)70:4<467::AID-IJC15>3.0.CO;2-C     Document Type: Article

References (11)

1. ARNOLD, A.M., BROWMAN, G.P., LEVINE, M.N., D'SOUZA, T., JOHNSTONE, B., SKINGLEY, P., TURNER-SMITH, L., CAYCO, R., BOOKER, L., NEWHOUSE, M. and HRYNIUK, W.M., The effect of the synthetic retinoid etretinate on sputum cytology-results from a randomized trial. Brit. J. Cancer 65, 737-743 (1992).
2. ARNOLD, A., KOWALESKI, B., TOZER, R. and HIRTE, H., The arotinoids: early clinical experience and discussion of future development. Leukemia, 11, 1817-1824 (1994).
3. EISENHAUER, E.A., LIPPMAN, S.M., KAVANAGH, J.J., PAREDES-ESPINOZA, M., ARNOLD, A., HONG, W.K., MASSIMINI, G., SCHLEUNIGER, U., BOLLAG, W., HOLDENER, E. and KRAKOFF, I., Combination 13-cis-retinoic acid and Interferon α2a in the therapy of solid tumours. Leukemia, 10, 1622-1625 (1994).
4. ELIASON, J.F., KAUFMANN, F., TANAKA, T. and TSUKAGUCHI, T., Antiproliferative effects of the arotinoid Ro 40-8757 on human cancer cell lines in vitro. Brit. J. Cancer, 67, 1293-1298 (1993).
5. GOODMAN, G.E., METCH, B.J. and OMENN, G.S., The effect of long-term beta-carotene and vitamin A administration on serum concentrations of alpha-tocopherol. Cancer Epidemiol. Biomarkers Prev., 3, 429-132 (1994).
6. HENNEKENS, C., BURING, J., MANSON, J., STAMPFER, M., ROSNER, B., COOK, N., BELANGER, C., LAMOTTE, F., GAZIANO, J., RIDKER, P., WILLETT, W. and PETO, R., Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. New Engl. J. Med., 334, 1145-1149 (1996).
7. KELLY, K., Evaluation of k-ras mutations in sputum samples by single stranded conformation polymorphism [Abstract]. Lang Cancer, 11 (Suppl.). 225 (1994).
8. LEE, J.S., LIPPMAN, S.M., BENNER, S.E., LEE, J.J., Ro, J.Y., LEUKEMAN, J.M., MORICE, R.C., PETERS, E.J., PANG, A.C., PRITSCHE, H.A. and HONG, W.K., Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. J. clin. Oncol. 12, 937-945 (1994).
9. MATHÉ, G., GOUVEIA, J. and HERCEND, T., Correlation between precancerous bronchial metaplasia and cigarette consumption, and preliminary results of retinoid treatment. Cancer Detect. Prevent., 5, 461-466 (1982).
10. OMENN, G., GOODMAN, G., THORNQUIST, M., BALMES, J., CULLEN, M., GLASS, A., KEUGH, J., MEYSKENS, F., VALANIS, B., WILLIAMS, J., BARNHART, S. and HAMMAR, S., Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. New Engl. J. Med., 334, 1150-1155 (1996).
11. OMENN, G.S., GOODMAN, G., THORNQUIST, M., GRIZZLE, J., ROSENSTOCK, L., BARNHART, S., BALMES, J., CHERNIACK, M.G., CULLEN, M.R. and GLASS, A., The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of luns cancer in high risk populations: smokers and asbestos-exposed workers. Cancer Res., 54 (Suppl). 2038s-2043s(1994).